Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. | Int J Surg | 2024 | 38742845 | PubTator, text mining | PubMed |
| Systematic epigenome editing captures the context-dependent instructive function of chromatin modifications. | Nat Genet | 2024 | 38724747 | PubTator, text mining | PubMed |
| Long-Term Globus Pallidus Internus Deep Brain Stimulation in Pediatric Non-Degenerative Dystonia: A Cohort Study and a Meta-Analysis. | Mov Disord | 2024 | 38646731 | PubTator, text mining | PubMed |
| Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. | Glob Med Genet | 2024 | 38628662 | PubTator, text mining | PubMed |
| Regulation of T helper cell differentiation by the interplay between histone modification and chromatin interaction. | Immunity | 2024 | 38614090 | PubTator, text mining | PubMed |
| Diagnostic utility of DNA methylation episignature analysis for early diagnosis of KMT2B-related disorders: case report. | Front Genet | 2024 | 38425714 | PubTator, text mining | PubMed |
| The molecular basis of cell memory in mammals: The epigenetic cycle. | Sci Adv | 2024 | 38416817 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma. | Head Neck | 2024 | 38362701 | PubTator, text mining | PubMed |
| Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells. | Cell Commun Signal | 2024 | 38347590 | PubTator, text mining | PubMed |
| Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma. | Diagn Pathol | 2024 | 38347522 | PubTator, text mining | PubMed |
| HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features. | Liver Cancer | 2024 | 38344447 | PubTator, text mining | PubMed |
| HNF4A guides the MLL4 complex to establish and maintain H3K4me1 at gene regulatory elements. | Commun Biol | 2024 | 38297077 | PubTator, text mining | PubMed |
| Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia. | Mov Disord Clin Pract | 2024 | 38291845 | PubTator, text mining | PubMed |
| Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. | BMC Med | 2024 | 38281914 | PubTator, text mining | PubMed |
| Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. | Cell Death Discov | 2024 | 38267442 | PubTator, text mining | PubMed |
| Regulation of adipogenesis by histone methyltransferases. | Differentiation | 2024 | 38241884 | PubTator, text mining | PubMed |
| Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. | Hered Cancer Clin Pract | 2024 | 38238849 | PubTator, text mining | PubMed |
| Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer. | Cell Commun Signal | 2024 | 38233864 | PubTator, text mining | PubMed |
| Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments. | Mol Cancer | 2024 | 38225603 | PubTator, text mining | PubMed |
| Type A Aortic Dissection in a 24-Year-Old Patient With Kabuki Syndrome. | JACC Case Rep | 2024 | 38223266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers?page=7